(Image: Getty/Kevron2001)

FDA aims to speed naloxone generics to market

By Ben Hargreaves

US FDA follows up the first generic approval of naloxone nasal spray by encouraging companies to apply with generic applications amid the North American opioid crisis.

(Image: Getty/greenleaf123)

FDA greenlights nine Lyrica generics

By Vassia Barba

Nine companies, including Teva, Alembic and Amneal receive US FDA approval for generic versions of Pfizer’s blockbuster Lyrica.


update - CEO: ideal model is two to four API plants and six to eight drug facilities

Teva confirms plan to reduce workforce by 14,000 to save $3bn

By Gareth Macdonald

Teva Pharmaceutical Industries will reduce its workforce by 14,000, rejig its generics portfolio and speed up optimization of its plant network as part of a $3bn (€2.5bn) cost saving plan.

Teva announced last week its plans to acquire Allergan

Success of Allergan integration is the human capital, says Teva

By Angela Coyle

"People are the essence of the company going forward," said Teva, referring to the news that the world's largest generic drug maker will purchase Allergan's generics business for $40.5bn, at its Q2 financial results press conference...

Complex generics will boost speciality biz, Teva says

Complex generics will boost speciality biz, Teva says

By Dan Stanton

Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business.

Teva Pharmaceuticals and P&G to do manufacturing in India

Teva makes first Indian forray with help of P&G

By Natalie Morrison

Teva Pharmaceuticals is set to build its first Indian production plant after finalising a pact with healthcare giant Procter & Gamble (P&G), according to local authorities.


Follow us


View more


Featured Suppliers